What is the recommended schedule for a 64-year-old to receive the pneumococcal (pneumonia) vaccine, specifically the pneumococcal conjugate vaccine (PCV13 or Prevnar 13) and pneumococcal polysaccharide vaccine (PPSV23 or Pneumovax23)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pneumococcal Vaccination Schedule for a 64-Year-Old

A 64-year-old should receive pneumococcal vaccination now if they have chronic medical conditions or immunocompromising conditions, but if they are healthy with no risk factors, they should wait until age 65 to receive a single dose of PCV20 or PCV21. 1, 2

For Healthy Adults Without Risk Factors

  • Wait until age 65 years, then receive a single dose of PCV20 (preferred) or PCV21 2, 3
  • This is a one-time vaccination with no additional doses needed 2, 4
  • The recommendation changed in October 2024 to include adults aged ≥50 years, so technically a healthy 64-year-old could receive vaccination now, but the traditional age-based recommendation remains at 65 years 5

For Adults Aged 19-64 Years With Chronic Medical Conditions

If the patient has chronic medical conditions (alcoholism, chronic heart disease including CHF/cardiomyopathies, chronic liver disease, chronic lung disease, diabetes, or smoking history), they should receive vaccination now at age 64. 1

Vaccination Schedule Based on Prior History:

  • Never vaccinated or only received PCV7: Give a single dose of PCV20 now 1, 4
  • Previously received PPSV23 only: Give a single dose of PCV20 after ≥1 year interval since the last PPSV23 dose 1, 4
  • Previously received PCV13 only: Give a single dose of PCV20 after ≥1 year interval since PCV13, OR give PPSV23 after ≥1 year interval and review recommendations again at age 65 1
  • Previously received both PCV13 and PPSV23: No vaccines recommended now; review recommendations again at age 65 1

For Adults Aged 19-64 Years With Immunocompromising Conditions

If the patient has immunocompromising conditions (chronic renal failure, asplenia, immunodeficiency, HIV, malignancy, immunosuppression, sickle cell disease, solid organ transplant), they should receive vaccination now with a more aggressive schedule. 1, 2

Vaccination Schedule Based on Prior History:

  • Never vaccinated or only received PCV7: Give a single dose of PCV20, OR give PCV15 followed by PPSV23 after ≥8 weeks 1
  • Previously received PPSV23 only: Give a single dose of PCV20 after ≥1 year interval since the last PPSV23 dose 1
  • Previously received PCV13 only: Give a single dose of PCV20 after ≥1 year interval, OR give PPSV23 after ≥8 weeks, then a second PPSV23 dose after ≥5 years 1

Key Clinical Considerations

The critical distinction is the interval between vaccines: immunocompromised patients need only ≥8 weeks between PCV and PPSV23, while non-immunocompromised patients need ≥1 year 3

Common pitfalls to avoid:

  • Not waiting the appropriate interval between different pneumococcal vaccines reduces immune response 4
  • Overlooking risk factors that would qualify a 64-year-old for immediate vaccination rather than waiting until age 65 1
  • Unnecessary revaccination—if PCV20 or PCV21 is used, the series is considered complete and no additional pneumococcal vaccination is generally needed 3, 4

The vaccination schedule differs significantly based on immune status: the ≥8 week interval for immunocompromised patients versus ≥1 year for others is a critical distinction that must not be overlooked 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pneumococcal Vaccination Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pneumococcal Vaccine Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pneumococcal Vaccination Schedule for Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.